Skip to main content
. Author manuscript; available in PMC: 2016 Feb 7.
Published in final edited form as: Lab Chip. 2015 Feb 7;15(3):882–888. doi: 10.1039/c4lc00999a

Fig. 4. The toxicity of doxorubucin (36 µM) on HSE-on-a-chip.

Fig. 4

(A) H&E staining of the HSE-on-a-chip after one week of doxorubucin treatment in comparison to untreated HSE-on-a-chip. (B) Immunostaining of Ki67 and Loricrin of HSE-on-a-chip treated with doxorubicin for a week. Scale bars: 100 µm